TRADING HALTED

Sinovac Biotech Ltd SVQ-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 02/22/19 CET
5.58UNCH (UNCH)
52 week range
0.00 - 5.58
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close5.58
  • 52 Week High5.58
  • 52 Week High Date02/22/19
  • 52 Week Low0.00
  • 52 Week Low Date-

Key Stats

  • Market Cap-
  • Shares Out99.5M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close5.58
  • 52 Week High5.58
  • 52 Week High Date02/22/19
  • 52 Week Low0.00
  • 52 Week Low Date-
  • Market Cap-
  • Shares Out99.5M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)32.13
  • P/E (TTM)0.17
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Sinovac Biotech Ltd

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Sinovac Biotech Ltd. (Sinovac) is a holding company. The Company is a biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases, including hepatitis A, hepatitis B, seasonal influenza, Haemagglutinase5 Neuraminidase1 (H5N1) and Influenza A (H1N1) pandemic influenza and mumps. The Company's pipeline consists of vaccine candidates in the clinical and pre-clinical...
WeiDong Yin
Chairman of the Board, President, Chief Executive Officer, Secretary
Qiang Gao
Chief Operating Officer, Vice President
Nan Wang
Chief Financial Officer, Vice President
Jing Li
Vice President - Quality and Production
Address
Haidian District, 39 Shangdi Xi Road
Beijing, BEJ
100085
China